Here’s our fortnightly wrap of all the news driving ASX health stocks.

Of the ASX’s 132-odd small cap health stocks and of those which were trading on Wednesday, 64 were in positive territory over the last fortnight, 11 were flat and 67 saw their share prices fall.

Code Name Price $ (July 8) 2 week return % 1 year return % Market cap
IMC IMMURON LTD 0.855 229 558 $152,433,920
MEB MEDIBIO LTD 0.013 117 -33 $17,519,614
MEM MEMPHASYS LTD 0.105 106 75 $79,167,256
RCE RECCE PHARMACEUTICALS LTD 1.35 99 500 $194,627,888
NOX NOXOPHARM LTD 0.365 70 -16 $77,818,208
ADO ANTEOTECH LTD 0.035 67 138 $57,543,180
FTT FACTOR THERAPEUTICS LTD 0.005 67 67 $5,214,178
GTG GENETIC TECHNOLOGIES LTD 0.01 67 79 $82,617,264
ATX AMPLIA THERAPEUTICS LTD 0.16 52 50 $16,207,041
RSH RESPIRI LTD 0.15 50 50 $97,925,968
JHL JAYEX HEALTHCARE LTD 0.036 44 -35 $6,349,069
IMM IMMUTEP LTD 0.21 35 0 $102,402,496
LCT LIVING CELL TECHNOLOGIES LTD 0.016 33 -27 $9,143,056
PAL PALLA PHARMA LTD 1 30 -7 $125,947,976
BXN BIOXYNE LTD 0.014 27 -39 $8,962,036
CDX CARDIEX LTD 0.033 27 18 $24,894,148
ANP ANTISENSE THERAPEUTICS LTD 0.105 24 150 $51,343,756
RAC RACE ONCOLOGY LTD 0.975 23 1850 $119,699,384
1ST 1ST GROUP LTD 0.04 21 -55 $16,984,676
IHL INCANNEX HEALTHCARE LTD 0.07 21 19 $52,936,260
ANR ANATARA LIFESCIENCES LTD 0.16 19 -47 $7,976,989
GMV G MEDICAL INNOVATION HOLDING 0.059 18 -70 $39,163,408
EYE NOVA EYE MEDICAL LTD 0.39 17 43 $56,004,444
IMU IMUGENE LTD 0.042 17 147 $185,890,768
PAB PATRYS LTD 0.014 17 -42 $15,731,325
PXS PHARMAXIS LTD 0.089 16 -61 $35,177,180
IBX IMAGION BIOSYSTEMS LTD 0.048 14 3 $36,565,448
MX1 MICRO-X LTD 0.16 14 -49 $57,146,856
RGS REGENEUS LTD 0.089 14 12 $24,726,424
OIL OPTISCAN IMAGING LTD 0.049 14 0 $23,411,162
PTX PRESCIENT THERAPEUTICS LTD 0.067 14 63 $26,415,462
GLH GLOBAL HEALTH LTD 0.3 13 68 $12,629,496
AT1 ATOMO DIAGNOSTICS LTD 0.39 13 $218,820,352
OSP OSPREY MEDICAL INC-CDI 0.046 12 -42 $68,944,288
SOM SOMNOMED LTD 1.39 12 4 $115,035,448
PIQ PROTEOMICS INTERNATIONAL LAB 0.48 12 41 $44,354,820
TD1 TALI DIGITAL LTD 0.029 12 142 $21,729,852
BOT BOTANIX PHARMACEUTICALS LTD 0.049 11 -80 $47,662,204
CYP CYNATA THERAPEUTICS LTD 0.695 11 -60 $81,401,184
BWX BWX LTD 4.17 11 93 $518,122,048
MMJ MMJ GROUP HOLDINGS LTD 0.1075 10 -62 $24,720,054
ICR INTELICARE HOLDINGS LTD 0.405 9 $29,524,380
MXC MGC PHARMACEUTICALS LTD 0.024 9 -54 $38,006,696
RHY RHYTHM BIOSCIENCES LTD 0.105 8 -51 $10,578,750
APH AUSTRALIAN PRIMARY HEMP LTD 0.135 8 -39 $9,416,943
ONT 1300 SMILES LTD 5.5 8 -9 $130,231,112
OSX OSTEOPORE LTD 0.625 8 $63,269,064
CTE CRYOSITE LTD 0.14 8 180 $6,560,339
SCU STEMCELL UNITED LTD 0.015 7 0 $9,624,125
ACR ACRUX LTD 0.155 7 -16 $26,143,146
CGS COGSTATE LTD 0.42 5 112 $71,460,968
BNO BIONOMICS LTD 0.065 5 59 $40,702,080
KZA KAZIA THERAPEUTICS LTD 0.55 5 41 $52,029,104
AGH ALTHEA GROUP HOLDINGS LTD 0.36 4 -70 $83,991,600
S66 STAR COMBO PHARMA LTD 0.4 4 -51 $54,246,640
RNO RHINOMED LTD 0.08 4 -75 $20,304,730
ALC ALCIDION GROUP LTD 0.155 3 -9 $153,557,584
JHC JAPARA HEALTHCARE LTD 0.52 3 -47 $138,968,608
OCC ORTHOCELL LTD 0.35 3 -20 $64,675,436
GSS GENETIC SIGNATURES LTD 2.62 2 113 $373,640,800
SDX SIENNA CANCER DIAGNOSTICS LT 0.07 1 17 $27,659,298
SDI SDI LTD 0.7 1 -19 $83,205,872
VHT VOLPARA HEALTH TECHNOLOGIES 1.46 1 -11 $363,954,752
CYC CYCLOPHARM LTD 1.51 1 4 $119,681,024
PBP PROBIOTEC LTD 1.995 0 25 $149,183,840
PYC PYC THERAPEUTICS LTD 0.125 0 363 $366,447,264
IPD IMPEDIMED LTD 0.071 0 -51 $73,479,976
CMP COMPUMEDICS LTD 0.42 0 -39 $74,408,440
VLS VITA LIFE SCIENCES LTD 0.57 0 -15 $30,827,088
NC6 NANOLLOSE LTD 0.041 0 -31 $4,335,750
NYR NYRADA INC-CDI 0.195 0 $21,329,826
SVA SIMAVITA LTD-CDI 0.019 0 -10 $10,711,785
CPH CRESO PHARMA LTD 0.031 0 -93 $11,233,823
ADR ADHERIUM LTD 0.025 0 -4 $15,047,658
FFC FARMAFORCE LTD 0.055 0 -63 $7,082,404
PSQ PACIFIC SMILES GROUP LTD 1.575 -1 37 $241,786,992
PAR PARADIGM BIOPHARMACEUTICALS 3.23 -1 98 $733,087,808
THC THC GLOBAL GROUP LTD 0.285 -2 -51 $49,347,364
ONE ONEVIEW HEALTHCARE PLC-CDI 0.043 -2 -85 $7,448,094
PGC PARAGON CARE LTD 0.175 -3 -63 $59,129,928
DXB DIMERIX LTD 0.35 -3 218 $69,212,256
1AD ADALTA LTD 0.097 -3 -46 $15,902,724
RHT RESONANCE HEALTH LTD 0.155 -3 19 $68,784,960
AHX APIAM ANIMAL HEALTH LTD 0.45 -3 0 $52,468,712
M7T MACH7 TECHNOLOGIES LTD 0.88 -3 19 $206,251,504
AC8 AUSCANN GROUP HOLDINGS LTD 0.145 -3 -64 $45,971,868
MDC MEDLAB CLINICAL LTD 0.145 -3 -67 $40,552,972
DVL DORSAVI LTD 0.028 -3 -44 $6,479,971
NEU NEUREN PHARMACEUTICALS LTD 1.23 -4 -13 $147,543,584
HLA HEALTHIA LTD 0.975 -4 8 $61,458,788
PCK PAINCHEK LTD 0.11 -4 -42 $113,907,464
MVF MONASH IVF GROUP LTD 0.53 -5 -58 $206,506,464
CAJ CAPITOL HEALTH LTD 0.21 -5 -1 $214,745,408
OPT OPTHEA LTD 2.32 -5 194 $624,446,016
EXL ELIXINOL GLOBAL LTD 0.17 -6 -95 $32,782,300
VBS VECTUS BIOSYSTEMS LTD 0.68 -6 100 $16,085,275
UBI UNIVERSAL BIOSENSORS INC-CDI 0.23 -6 -8 $40,816,612
BD1 BARD1 LIFE SCIENCES LTD 0.028 -7 -7 $38,281,180
OVN OVENTUS MEDICAL LTD 0.265 -7 -48 $41,932,992
ATH ALTERITY THERAPEUTICS LTD 0.037 -8 37 $40,145,148
AZV AZURE HEALTHCARE LTD 0.073 -8 -8 $20,745,794
ZLD ZELIRA THERAPEUTICS LTD 0.053 -9 -20 $51,544,004
NSB NEUROSCIENTIFIC BIOPHARMACEU 0.21 -9 -25 $16,460,763
BIT BIOTRON LTD 0.1 -9 16 $70,193,272
IDT IDT AUSTRALIA LTD 0.15 -9 -6 $35,896,956
CDY CELLMID LTD 0.135 -10 -33 $16,908,326
CP1 CANNPAL ANIMAL THERAPEUTICS 0.135 -10 -25 $12,571,875
PNV POLYNOVO LTD 2.36 -10 43 $1,560,167,808
MVP MEDICAL DEVELOPMENTS INTERNA 6.33 -11 5 $415,396,704
NXS NEXT SCIENCE LTD 1.31 -11 -66 $237,826,144
OSL ONCOSIL MEDICAL LTD 0.115 -12 117 $95,289,104
ACW ACTINOGEN MEDICAL LTD 0.022 -12 120 $24,557,090
AVE AVECHO BIOTECHNOLOGY LTD 0.007 -13 75 $11,182,202
MDR MEDADVISOR LTD 0.48 -13 49 $118,424,656
ICS ICSGLOBAL LTD 1.7 -13 79 $18,026,832
RAP RESAPP HEALTH LTD 0.135 -13 -13 $101,941,128
TLX TELIX PHARMACEUTICALS LTD 1.33 -13 -20 $337,746,112
PAA PHARMAUST LTD 0.19 -14 280 $59,108,252
LSH LIFESPOT HEALTH LTD 0.04 -15 -43 $3,871,532
SUD SUDA PHARMACEUTICALS LTD 0.028 -18 -56 $4,409,887
VTI VISIONEERING TECH-CDI 0.017 -19 -74 $15,418,144
IVX INVION LTD 0.008 -20 -47 $44,004,852
ALT ANALYTICA LTD 0.002 -20 -60 $7,039,225
NTI NEUROTECH INTERNATIONAL LTD 0.008 -20 -68 $1,721,725
ZNO ZOONO GROUP LTD 2.32 -23 2567 $379,581,472
LBT LBT INNOVATIONS LTD 0.145 -24 12 $41,403,268
UCM USCOM LTD 0.195 -25 44 $29,216,526
ESE ESENSE-LAB LTD-CDI 0.018 -25 -25 $9,180,684
BPH BPH ENERGY LTD 0.017 -26 70 $6,345,026
CAN CANN GROUP LTD 0.66 -27 -69 $94,308,944
AMT ALLEGRA ORTHOPAEDICS LTD 0.215 -33 65 $22,444,396
HCT HOLISTA COLLTECH LTD 0.08 -45 27 $22,027,926

 

Immuron (ASX:IMC) is raising $US20m on the back of news that one of its drug candidates might help with COVID-19 symptoms.

While it’s better known for its travellers’ diarrhoea pills, a petri dish assessment of IMM-124E demonstrated neutralising activity against the virus, meaning it was able to inhibit replication.

Immuron’s theory is that diarrhoea is a common symptom in another coronavirus, bovine coronavirus, and it’s becoming an increasingly common COVID-19 symptom.

The US Centre for Disease Control and Prevention recently included it on its list of symptoms, while the inner-gut lining expresses high amounts of an enzyme which COVID-19 uses to gain entry into cells.

Medibio (ASX:MEB), which has a corporate well-being product ilumen, which screens people for symptoms of depression, anxiety, and stress, was up for no discernible reason.

As pointed out by Stockhead however, it submitted an application for FDA approval at the end of April for its sleep staging software MEBsleep, a system that uses artificial intelligence and “neural network methodology” to identify changes in the five stages of sleep necessary to diagnose sleep disorders.

It expects that process to take about four months, meaning a decision should come around the end of August, all things going well.

 

On the cusp of making money

Sperm separator Memphasys (ASX:MEM) is moving into the commercialisation (read: money making) phase and rewarded its executives with vested performance options.

The milestone reached to allow the vesting was passing all legal and regulatory hurdles for distribution into Canada.

Commercial sales are expected to start once the company has completed verification and validation tests on the final manufactured product, around the December quarter this year — bang on when the company has guided that sales will start.

Recce Pharmaceuticals (ASX:RCE) went on a run after two of its compounds were selected to be part of COVID-19 tests run by the CSIRO and the Doherty Institute.

One of the compounds is among only few qualified treatments for sepsis or blood poisoning that also has a great capability against a broad range of superbugs, and is one of the first new anti-infectives to be developed in the last 30 years.

Recce’s youthful boss James Graham, 30, famously put his $100,000 house deposit into the drug company early last year.

And controversial cancer hopeful Noxopharm (ASX:NOX) says pre-clinical data from two research groups confirms that idronoxil, the active ingredient in its main drug candidate Veyonda helps restore immune function within ‘COLD’ micro-tumours by converting them to ‘HOT’.

A COLD tumour is one that contains few infiltrating T cells and are not recognised and do not provoke a strong response by the immune system, making them difficult to treat with current immunotherapies.